Genocea Biosciences Inc reports results for the quarter ended in March - Earnings Summary

Genocea Biosciences

29/04/2021 22:32

* Genocea Biosciences Inc  GNCA.OQ  reported a quarterly
adjusted loss of 17 cents​​ per share for the quarter ended
in March. The mean expectation of five analysts for the quarter
was for a loss of 20 cents per share.
* Revenue was $0.00​​;  analysts expected $0.00.
* Genocea Biosciences Inc's reported EPS for the quarter was a
loss of 17 cents​.
* The mean earnings estimate of analysts had risen by
about 12.6% in the last three months.​ 
* In the last 30 days one analyst negatively revised an earnings
estimate and  
* Genocea Biosciences Inc shares had fallen by 4.1% this
quarter and gained 7.4% so far this year.
* The company reported a quarterly loss of $11.98 million.
* Wall Street's median 12-month price target for Genocea
Biosciences Inc is $6.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated April 29 at 09:32 p.m. GMT.
​All figures in US Dollars.​